Literature DB >> 26550535

PET studies in epilepsy.

Ismet Sarikaya1.   

Abstract

Various PET studies, such as measurements of glucose, serotonin and oxygen metabolism, cerebral blood flow and receptor bindings are availabe for epilepsy. (18)Fluoro-2-deoxyglucose ((18)F-FDG) PET imaging of brain glucose metabolism is a well established and widely available technique. Studies have demonstrated that the sensitivity of interictal FDG-PET is higher than interictal SPECT and similar to ictal SPECT for the lateralization and localization of epileptogenic foci in presurgical patients refractory to medical treatments who have noncontributory EEG and MRI. In addition to localizing epileptogenic focus, FDG-PET provide additional important information on the functional status of the rest of the brain. The main limitation of interictal FDG-PET is that it cannot precisely define the surgical margin as the area of hypometabolism usually extends beyond the epileptogenic zone. Various neurotransmitters (GABA, glutamate, opiates, serotonin, dopamine, acethylcholine, and adenosine) and receptor subtypes are involved in epilepsy. PET receptor imaging studies performed in limited centers help to understand the role of neurotransmitters in epileptogenesis, identify epileptic foci and investigate new treatment approaches. PET receptor imaging studies have demonstrated reduced (11)C-flumazenil (GABAA-cBDZ) and (18)F-MPPF (5-HT1A serotonin) and increased (11)C-cerfentanil (mu opiate) and (11)C-MeNTI (delta opiate) bindings in the area of seizure. (11)C-flumazenil has been reported to be more sensitive than FDG-PET for identifying epileptic foci. The area of abnormality on GABAAcBDZ and opiate receptor images is usually smaller and more circumscribed than the area of hypometabolism on FDG images. Studies have demonstrated that (11)C-alpha-methyl-L-tryptophan PET (to study synthesis of serotonin) can detect the epileptic focus within malformations of cortical development and helps in differentiating epileptogenic from non-epileptogenic tubers in patients with tuberous sclerosis complex. (15)O-H2O PET was reported to have a similar sensitivity to FDG-PET in detecting epileptic foci.

Entities:  

Keywords:  Epilepsy; FDG; Neurotransmitter; PET; receptor

Year:  2015        PMID: 26550535      PMCID: PMC4620171     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  108 in total

1.  Ictal cerebral positron emission tomography (PET) in focal status epilepticus.

Authors:  Francesca Siclari; John O Prior; Andrea O Rossetti
Journal:  Epilepsy Res       Date:  2013-04-11       Impact factor: 3.045

2.  FDG-PET in the diagnosis of complex partial status epilepticus originating from the frontal lobe.

Authors:  Aaron Stayman; Bassel Abou-Khalil
Journal:  Epilepsy Behav       Date:  2011-03-25       Impact factor: 2.937

3.  The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery.

Authors:  Chaturbhuj Rathore; John C Dickson; Rute Teotónio; Peter Ell; John S Duncan
Journal:  Epilepsy Res       Date:  2014-07-07       Impact factor: 3.045

4.  FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome.

Authors:  W H Theodore; S Sato; C V Kufta; W D Gaillard; K Kelley
Journal:  Epilepsia       Date:  1997-01       Impact factor: 5.864

Review 5.  [18F] fluorodeoxyglucose-positron-emission tomography and MR imaging coregistration for presurgical evaluation of medically refractory epilepsy.

Authors:  K K Lee; N Salamon
Journal:  AJNR Am J Neuroradiol       Date:  2009-07-23       Impact factor: 3.825

6.  Interictal and postictal focal hypermetabolism on positron emission tomography.

Authors:  H T Chugani; D A Shewmon; S Khanna; M E Phelps
Journal:  Pediatr Neurol       Date:  1993 Jan-Feb       Impact factor: 3.372

7.  Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy.

Authors:  Joon Young Choi; Sun Jung Kim; Seung Bong Hong; Dae Won Seo; Seung Chyul Hong; Byung-Tae Kim; Sang Eun Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-30       Impact factor: 9.236

8.  Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy.

Authors:  S S Ho; S F Berkovic; S U Berlangieri; M R Newton; G F Egan; H J Tochon-Danguy; W J McKay
Journal:  Ann Neurol       Date:  1995-06       Impact factor: 10.422

9.  In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat model.

Authors:  Hongyoon Choi; Yu Kyeong Kim; So Won Oh; Hyung-Jun Im; Do Won Hwang; Hyejin Kang; Boeun Lee; Yun-Sang Lee; Jae Min Jeong; E Edmund Kim; June-Key Chung; Dong Soo Lee
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  Periventricular [(11)C]flumazenil binding for predicting postoperative outcome in individual patients with temporal lobe epilepsy and hippocampal sclerosis.

Authors:  Josiane Yankam Njiwa; Sandrine Bouvard; Hélène Catenoix; François Mauguiere; Philippe Ryvlin; Alexander Hammers
Journal:  Neuroimage Clin       Date:  2013-09-03       Impact factor: 4.881

View more
  29 in total

1.  Direct attenuation correction of brain PET images using only emission data via a deep convolutional encoder-decoder (Deep-DAC).

Authors:  Isaac Shiri; Pardis Ghafarian; Parham Geramifar; Kevin Ho-Yin Leung; Mostafa Ghelichoghli; Mehrdad Oveisi; Arman Rahmim; Mohammad Reza Ay
Journal:  Eur Radiol       Date:  2019-06-21       Impact factor: 5.315

Review 2.  Anaesthesia for epilepsy surgery.

Authors:  C M Larkin; D F O'Brien; D Maheshwari
Journal:  BJA Educ       Date:  2019-09-26

3.  The PET Sandwich: Using Serial FDG-PET Scans with Interval Burst Suppression to Assess Ictal Components of Disease.

Authors:  Feras Akbik; Matthew Robertson; Alvin S Das; Tarun Singhal; Jong Woo Lee; Henrikas Vaitkevicius
Journal:  Neurocrit Care       Date:  2020-12       Impact factor: 3.210

Review 4.  Imaging biomarkers of epileptogenecity after traumatic brain injury - Preclinical frontiers.

Authors:  Riikka Immonen; Neil G Harris; David Wright; Leigh Johnston; Eppu Manninen; Gregory Smith; Afshin Paydar; Craig Branch; Olli Grohn
Journal:  Neurobiol Dis       Date:  2018-10-12       Impact factor: 5.996

Review 5.  The central nervous system manifestations of localized craniofacial scleroderma: a study of 10 cases and literature review.

Authors:  Ezekiel Maloney; Sarah J Menashe; Ramesh S Iyer; Sarah Ringold; Amit K Chakraborty; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2018-07-03

6.  Investigation of Axial and Angular Sampling in Multi-Detector Pinhole-SPECT Brain Imaging.

Authors:  Navid Zeraatkar; Kesava S Kalluri; Benjamin Auer; Arda Konik; Timothy J Fromme; Lars R Furenlid; Phillip H Kuo; Michael A King
Journal:  IEEE Trans Med Imaging       Date:  2020-11-30       Impact factor: 10.048

7.  Burst suppression uncovers rapid widespread alterations in network excitability caused by an acute seizure focus.

Authors:  Jyun-You Liou; Eliza Baird-Daniel; Mingrui Zhao; Andy Daniel; Catherine A Schevon; Hongtao Ma; Theodore H Schwartz
Journal:  Brain       Date:  2019-10-01       Impact factor: 13.501

Review 8.  Recent Advances in Neuroimaging of Epilepsy.

Authors:  Adam M Goodman; Jerzy P Szaflarski
Journal:  Neurotherapeutics       Date:  2021-05-03       Impact factor: 7.620

9.  Cerebral Hemodynamic Evaluation of Main Cerebral Vessels in Epileptic Patients Based on Transcranial Doppler.

Authors:  Jihong Meng; Chun Li; Weining Ma
Journal:  Front Neurol       Date:  2021-05-20       Impact factor: 4.003

10.  18F-FDG PET-guided diffusion tractography reveals white matter abnormalities around the epileptic focus in medically refractory epilepsy: implications for epilepsy surgical evaluation.

Authors:  Stefan E Poirier; Benjamin Y M Kwan; Michael T Jurkiewicz; Lina Samargandy; David A Steven; Ana Suller-Marti; Victor Lam Shin Cheung; Ali R Khan; Jonathan Romsa; Frank S Prato; Jorge G Burneo; Jonathan D Thiessen; Udunna C Anazodo
Journal:  Eur J Hybrid Imaging       Date:  2020-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.